Literature DB >> 18780322

Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.

Ian D Schnadig1, Erik K Fromme, Charles L Loprinzi, Jeff A Sloan, Motomi Mori, Hong Li, Tomasz M Beer.   

Abstract

BACKGROUND: Physician-reported performance status (PS) is an important prognostic factor and frequently influences treatment decisions. To the authors' knowledge, the extent, prognostic importance, and predictors of disagreements in PS assessment between physicians and patients have not been adequately examined.
METHODS: Using North Central Cancer Treatment Group (NCCTG) clinical trial data from 1987 through 1990, the authors compared PS (Eastern Cooperative Oncology Group [ECOG] and Karnofsky [KPS]) and nutrition scores reported by physicians and patients individually. Differences were analyzed using a Student t test for paired data and degree of disagreement by kappa statistic. The effect of disagreement on overall survival was determined by the Kaplan-Meier method and Cox regression analysis. Predictors of disagreement were identified by logistic regression.
RESULTS: In all, 1636 patients with advanced lung and colorectal cancer had a median survival of 9.8 months (95% confidence interval [95% CI], 9.4-10.4 months). Percent disagreement between patients and physicians regarding KPS, ECOG PS, and nutrition score were 67.1%, 56.6%, and 58.0%, respectively. Physicians were more likely to rate patients better than individual patients were to rate themselves: ECOG (mean 0.91 vs 1.30; P < .0001), KPS (mean 83.3 vs 81.7; P < .0001), and nutrition score (mean 1.6 vs 2.1; P < .0001). Disagreement between patients and their physicians was associated with increased risk of death: KPS (hazards ratio [HR] of 1.16; 95% CI, 1.04-1.30 [P = .008]) and nutrition scores (HR of 1.44; 95% CI, 1.29-1.61 [P < .0001]) after adjustment for covariates. Patient sociodemographic factors that predict disagreement were identified.
CONCLUSIONS: Physicians and patients frequently disagree regarding PS and nutritional status. Disagreement is associated with an increased risk of death in patients with advanced malignancies. These findings illustrate the limitations of physician-only assessed PS. (c) 2008 American Cancer Society.

Entities:  

Mesh:

Year:  2008        PMID: 18780322      PMCID: PMC3580230          DOI: 10.1002/cncr.23856

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

1.  Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care.

Authors:  M Maltoni; O Nanni; M Pirovano; E Scarpi; M Indelli; C Martini; M Monti; E Arnoldi; L Piva; A Ravaioli; G Cruciani; R Labianca; D Amadori
Journal:  J Pain Symptom Manage       Date:  1999-04       Impact factor: 3.612

2.  Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition.

Authors:  N J Vogelzang; W Breitbart; D Cella; G A Curt; J E Groopman; S J Horning; L M Itri; D H Johnson; S L Scherr; R K Portenoy
Journal:  Semin Hematol       Date:  1997-07       Impact factor: 3.851

3.  Whose opinion counts?

Authors:  Charles L Loprinzi; Debra L Barton; Jeff A Sloan
Journal:  J Clin Oncol       Date:  2006-10-30       Impact factor: 44.544

4.  Prognostic disclosure to patients with cancer near the end of life.

Authors:  E B Lamont; N A Christakis
Journal:  Ann Intern Med       Date:  2001-06-19       Impact factor: 25.391

5.  Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.

Authors:  C L Loprinzi; J W Kugler; J A Sloan; J A Mailliard; J E Krook; M B Wilwerding; K M Rowland; J K Camoriano; P J Novotny; B J Christensen
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

6.  A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index.

Authors:  J A Sloan; C L Loprinzi; J A Laurine; P J Novotny; D Vargas-Chanes; J E Krook; M J O'Connell; J W Kugler; M T Tirona; C G Kardinal; M Wiesenfeld; L K Tschetter; A K Hatfield; P L Schaefer
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

7.  Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data.

Authors:  P Hopwood; R J Stephens
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

8.  Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study.

Authors:  N A Christakis; E B Lamont
Journal:  BMJ       Date:  2000-02-19

9.  Relationship between cancer patients' predictions of prognosis and their treatment preferences.

Authors:  J C Weeks; E F Cook; S J O'Day; L M Peterson; N Wenger; D Reding; F E Harrell; P Kussin; N V Dawson; A F Connors; J Lynn; R S Phillips
Journal:  JAMA       Date:  1998-06-03       Impact factor: 56.272

10.  The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting.

Authors:  V Mor; L Laliberte; J N Morris; M Wiemann
Journal:  Cancer       Date:  1984-05-01       Impact factor: 6.860

View more
  52 in total

1.  Variability of performance status assessment between patients with hematologic malignancies and their physicians.

Authors:  Alexis D Leal; Cristine Allmer; Matthew J Maurer; Tait D Shanafelt; James R Cerhan; Brian K Link; Carrie A Thompson
Journal:  Leuk Lymphoma       Date:  2017-07-18

2.  Distinct Physical Function Profiles in Older Adults Receiving Cancer Chemotherapy.

Authors:  Christine Miaskowski; Melisa L Wong; Bruce A Cooper; Judy Mastick; Steven M Paul; Katherine Possin; Michael Steinman; Janine Cataldo; Laura B Dunn; Christine Ritchie
Journal:  J Pain Symptom Manage       Date:  2017-07-15       Impact factor: 3.612

3.  Patient-reported outcomes are associated with patient-oncologist agreement of performance status in a multi-ethnic Asian population.

Authors:  Chun Fan Lee; Raymond Ng; Nan Luo; Yin Bun Cheung
Journal:  Support Care Cancer       Date:  2014-07-03       Impact factor: 3.603

4.  Stability of Symptom Clusters in Patients With Lung Cancer Receiving Chemotherapy.

Authors:  Jacquelyn Russell; Melisa L Wong; Lynda Mackin; Steven M Paul; Bruce A Cooper; Marilyn Hammer; Yvette P Conley; Fay Wright; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2019-02-13       Impact factor: 3.612

5.  Longitudinal patient-reported performance status assessment in the cancer clinic is feasible and prognostic.

Authors:  Sang-Yeon Suh; Thomas W Leblanc; Rebecca A Shelby; Gregory P Samsa; Amy P Abernethy
Journal:  J Oncol Pract       Date:  2011-11       Impact factor: 3.840

6.  Effects of nutritional and psychological status of the patients with advanced stomach cancer on physical performance status.

Authors:  Jun Tian; Zhen-chun Chen; Li-Fang Hang
Journal:  Support Care Cancer       Date:  2009-01-27       Impact factor: 3.603

7.  Geriatric assessment-identified deficits in older cancer patients with normal performance status.

Authors:  Trevor A Jolly; Allison M Deal; Kirsten A Nyrop; Grant R Williams; Mackenzi Pergolotti; William A Wood; Shani M Alston; Brittaney-Belle E Gordon; Samara A Dixon; Susan G Moore; W Chris Taylor; Michael Messino; Hyman B Muss
Journal:  Oncologist       Date:  2015-03-12

8.  Characteristics Associated With Physical Function Trajectories in Older Adults With Cancer During Chemotherapy.

Authors:  Melisa L Wong; Steven M Paul; Judy Mastick; Christine Ritchie; Michael A Steinman; Louise C Walter; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2018-08-23       Impact factor: 3.612

9.  Co-occurrence of decrements in physical and cognitive function is common in older oncology patients receiving chemotherapy.

Authors:  Inger Utne; Bruce A Cooper; Christine Ritchie; Melisa Wong; Laura B Dunn; Borghild Loyland; Ellen Karine Grov; Marilyn J Hammer; Steven M Paul; Jon D Levine; Yvette P Conley; Kord M Kober; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2020-08-03       Impact factor: 2.398

10.  Congruence Between Latent Class and K-Modes Analyses in the Identification of Oncology Patients With Distinct Symptom Experiences.

Authors:  Nikoloas Papachristou; Payam Barnaghi; Bruce A Cooper; Xiao Hu; Roma Maguire; Kathi Apostolidis; Jo Armes; Yvette P Conley; Marilyn Hammer; Stylianos Katsaragakis; Kord M Kober; Jon D Levine; Lisa McCann; Elisabeth Patiraki; Steven M Paul; Emma Ream; Fay Wright; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2017-08-30       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.